D.E. Shaw & Co’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-59,923
| Closed | -$712K | – | 3300 |
|
|
2025
Q1 | $712K | Sell |
59,923
-52,918
| -47% | -$629K | ﹤0.01% | 2321 |
|
|
2024
Q4 | $2.13M | Buy |
112,841
+40,001
| +55% | +$754K | ﹤0.01% | 1769 |
|
|
2024
Q3 | $1.64M | Buy |
+72,840
| New | +$1.64M | ﹤0.01% | 1907 |
|
|
2023
Q4 | – | Sell |
-25,358
| Closed | -$199K | – | 3259 |
|
|
2023
Q3 | $199K | Sell |
25,358
-26,144
| -51% | -$205K | ﹤0.01% | 2591 |
|
|
2023
Q2 | $515K | Sell |
51,502
-7,535
| -13% | -$75.3K | ﹤0.01% | 2337 |
|
|
2023
Q1 | $524K | Sell |
59,037
-32,672
| -36% | -$290K | ﹤0.01% | 2493 |
|
|
2022
Q4 | $1.01M | Buy |
91,709
+31,695
| +53% | +$348K | ﹤0.01% | 2426 |
|
|
2022
Q3 | $782K | Buy |
+60,014
| New | +$782K | ﹤0.01% | 2668 |
|
|
2021
Q3 | – | Sell |
-24,012
| Closed | -$637K | – | 3771 |
|
|
2021
Q2 | $637K | Sell |
24,012
-17,186
| -42% | -$456K | ﹤0.01% | 2771 |
|
|
2021
Q1 | $1.28M | Buy |
+41,198
| New | +$1.28M | ﹤0.01% | 2043 |
|